Market Tracker

09/03 6:01pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

During the Trading Day
40.89 -0.26 / -0.63%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
40.89 0.00 / 0.00%
 
Volume: 15.4K

Today’s Trading

Previous close41.15
Today’s open41.49
Day’s range40.69 - 41.65
Volume498,231
Average volume (3 months)806,637
Market cap$3.0B
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)-0.94%
Earnings growth (next 5 years)+30.75%
Revenue growth (last year)+16.53%
P/E ratio373.1
Price/Sales3.75
Price/Book3.30

Competitors

 Today’s
change
Today’s
% change
WXWuXi PharmaTech (Cay...+0.12+0.28%
PBYIPuma Biotechnology I...-3.91-4.14%
MDCOMedicines Co-1.52-3.65%
CLVSClovis Oncology Inc-1.97-2.36%
Data as of 4:02pm ET, 09/03/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.40
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts